A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
A resource hub for all things Premier.
Find what you’re looking for, fast! Select a category or topic to get to what matters to you most.
Premier urges the FDA to leverage its statutory authority to support a more resilient pharmaceutical supply chain.
Seven of Premier’s most pioneering healthcare suppliers, their products and the ways that they're helping to improve the health of communities will be celebrated.
Premier data highlights three key factors that contributed to recent drug shortages.
Automated buying experience with complete visibility into procurement will help drive healthcare supply chain resiliency, savings opportunities and quality patient care across the care continuum.
Premier applauds legislation to establish an automated supply-chain tracking application that provides insight into critical medical supplies across the country.
Premier's Karen Niven highlights the essential role of change management in successful healthcare value analysis programs.
Premier reflects on the lessons learned during recent pandemic response efforts and provides Congress with detailed recommendations to address critical national security threats.
Remitra® can help minimize burnout and turnover associated with overwhelming manual workloads and give staff time for more challenging work that drives healthcare forward.
Premier’s Chief Pharmacy Officer Jessica Daley joins a panel of experts to discuss strategies to manage and mitigate drug shortages.
In this Executive Roundtable sponsored by Remitra®, participants discussed ways to relieve labor cost increases, inflation, declining Medicare reimbursements and clawbacks.
See the highlights from the grand opening event for a new Premier-led joint venture established to manufacture vital healthcare products in Norfolk, VA.
Actionable Insights |
Premier's David Hargraves discusses the current and future state of the healthcare supply chain as we emerge from the global pandemic.